Call
+918447748545

Published on: Jul 22, 2020
2 minute read
By: Dr Rajan Choudhary

The Oxford Vaccine

Recently we wrote a blog on the success of an RNA vaccine against SARS-CoV-2, the virus responsible for COVID-19. Within just a few weeks of that incredible research breakthrough, researchers at Oxford University’s Jenner Institute have announced a COVID vaccine that has induced remarkable immune response against the virus.

This study was published in the Lancet, one of the most prestigious medical journals in the world, and a simple summary suggests the vaccine has no early safety concern and is able to induce a strong immune response with both T cells and B cell/antibodies.

THE VACCINE

ChAdOx1 nCoV-19, now known as AZD1222, was co-developed by the University of Oxford and one of its spin-off companies, Vaccitech. The vaccine uses a viral vector based on a common cold virus (adenovirus). This carries genetic material for the SARS-CoV-2 spike protein. In our previous blog, we saw how the spike proteins are used by the virus to target and fuse with our target cells, allowing the virus to invade, replicate and ultimately cause the disease known as COVID. It is also a good target for the human immune system to recognize and attack.

The viral vector delivers the genetic material inside our cells. The spike protein is then produced by our cells, recognized by the immune system as a viral target, and an immune response is created against it. This can be antibodies, which recognize, attach to and mark the virus in our blood, allowing for other white blood cells to destroy the virus.

In this case, the vaccine also produced a T cell response. T cells can recognize cells infected by a virus-based on the markers present on the surface of infected cells. They can tell an infected cell to destroy itself, thereby destroying the virus within without spreading the infection. They also have other functions that we will not discuss in this blog.

THE STUDY

This study was a Phase I/II trial that started in April using the vaccine named ChAdOx1 nCoV-19. This vaccine development started in January 2020, and progress on development has been incredibly rapid. Whilst our previous study had just 45 people, this study looked reviewed over 1,000 healthy adults. 10 of these participants received two doses of the vaccine.

In a study the more participants there are, the greater the power of the study. If the vaccine has any side effects, even ones that rarely occur, it is more likely to be picked up in studies with more people. Similarly having more people helps show that the vaccine is effective, and the strong responses are not merely a fluke or accident. Another benefit of this study is it was able to compare the vaccine against a control group. This shows the results were not simply a placebo and allowed comparison of side effects as well.

The majority of side effects were feeling feverish, chills, muscle ache, headache, and malaise, all symptoms treatable with paracetamol. None of the participants had any serious side effects. It took just 14 days to create a T cell response, and 28 days to make strong antibodies. In 91% of patients, this was enough to neutralize the COVID coronavirus. Receiving two doses gave an even stronger antibody response, and all participants were able to stop the virus.

WHAT NEXT

The news from the University of Oxford is needed, as infection rate and mortality continue to increase in countries such as the US and Brazil. The ability to induce an antibody response without causing harm to the patient shows we have made huge progress in the fight against COVID-19. Further Large scale Phase III trials been set up through a global partnership, and include studies in the US with over 30,000 patients, studies in children as well as some in low to middle-income countries.

If successful a vaccine would be essential in preventing a second wave of COVID in the winter when the elderly population is most at risk. And it would be the key to restarting the economy and getting our everyday lives back to where it was pre-pandemic.

Read Blog

AI-Based Disease Detection India: How SecondMedic Is Transforming Early Diagnosis

India’s healthcare landscape is evolving rapidly, with artificial intelligence emerging as one of the most powerful tools for early disease detection. AI-based disease detection India represents a major shift from reactive healthcare to predictive, preventive, and precise medical analysis. Instead of waiting for symptoms to appear, AI enables clinicians and patients to identify risks early through advanced data interpretation.

Rising chronic diseases, increased diagnostic loads, and limited specialist availability make AI essential for early diagnosis in India. The use of AI in medical imaging, risk scoring, and pattern recognition significantly enhances accuracy while reducing time-consuming manual processes. SecondMedic integrates AI-powered diagnostic tools to help individuals detect health conditions in their earliest stages, enabling timely intervention and improved long-term outcomes.

Why India Needs AI-Based Disease Detection

India faces one of the world’s highest burdens of chronic and lifestyle diseases. Many conditions remain undiagnosed until they reach advanced stages, often due to late screenings, limited access to specialists, or lack of early symptoms.

The need for AI-based detection is driven by:

High incidence of silent diseases like diabetes and hypertension
Overloaded healthcare systems
Limited availability of expert radiologists
Rising lifestyle risk factors
Increasing demand for precision diagnostics
Need for faster, more accurate analysis

AI bridges these gaps by providing early alerts, consistent accuracy, and fast interpretations.

How AI Detects Diseases Early

AI-based disease detection uses machine learning models trained on thousands of medical datasets. These models learn to recognize abnormal patterns and subtle changes that the human eye might overlook.

AI analyzes:

Blood test patterns
Vital signs and wearable data
Imaging scans (X-rays, MRIs, CT scans)
Medical history
Genetic predispositions
Lifestyle habits

Through advanced algorithms, AI can identify risks long before symptoms appear, giving patients critical time for prevention and treatment.

AI in Medical Imaging: A Major Breakthrough for India

Medical imaging AI has transformed diagnosis speed and accuracy. In India, where access to radiologists is uneven, AI helps bridge diagnostic gaps.

AI-assisted imaging helps detect:

Lung infections and tuberculosis
Early-stage cancer indicators
Cardiac abnormalities
Brain tumors and neurological issues
Bone fractures and musculoskeletal conditions
Liver and kidney anomalies

SecondMedic uses AI-supported imaging interpretation to enhance precision and reduce reporting delays.

AI for Chronic Disease Prediction

Chronic illnesses often develop silently. By analyzing long-term trends, AI can predict disease progression and alert patients earlier.

AI helps forecast:

Prediabetes to diabetes progression
Heart attack risk
Hypertension development
Chronic kidney disease
Thyroid dysfunction
Metabolic health decline

These predictions allow individuals to take preventive action far in advance.

Personalized Disease Detection with AI

AI enables personalized diagnostics by incorporating each user’s biological and lifestyle data into prediction models.

Personalized AI detection considers:

Age and family history
Diet and activity levels
Sleep patterns
Stress levels
Blood markers
Genetic factors

This creates a highly individualized health risk profile.

SecondMedic’s AI engine creates a personalized risk score for each user, allowing targeted preventive strategies.

AI for Cancer Early Detection

Cancer often goes undiagnosed until it reaches advanced stages. AI helps detect early warning signs by analyzing subtle abnormalities.

AI supports early cancer detection in:

Breast cancer (mammograms)
Cervical cancer (Pap tests and visual scans)
Lung cancer (X-rays and CT scans)
Colon cancer indicators
Skin cancer lesion analysis

This improves survival rates by supporting early diagnosis.

Real-Time Monitoring with AI

Continuous monitoring is essential for early disease detection. AI integrates with wearable devices and digital health tools to track vital parameters in real time.

AI monitors:

Heart rate trends
Oxygen levels
Blood pressure variations
Stress levels
Sleep quality
Blood glucose fluctuations (connected devices)

Real-time alerts notify users of abnormalities that require attention.

AI in Public Health Disease Detection

AI is also used at the population level to identify disease patterns and outbreaks.

AI supports public health by:

Predicting outbreak patterns
Analyzing environmental health impact
Tracking regional disease trends
Supporting government screening programs

This strengthens India’s preventive health strategy.

How SecondMedic Uses AI for Disease Detection

SecondMedic integrates AI tools throughout its digital healthcare ecosystem, helping individuals access early detection and preventive insights.

SecondMedic’s AI capabilities include:

Risk scoring for diseases
AI analysis of medical reports
Predictive analytics dashboards
Early-warning alerts
Integration with wearables
AI-supported doctor consultations

This helps users understand risks clearly and take action early.

Challenges in AI-Based Disease Detection

While AI offers powerful benefits, it must be used responsibly.

Challenges include:

Requirement of high-quality medical data
Need for clinical validation
Maintaining data privacy
Avoiding algorithmic bias
Ensuring user awareness and understanding

SecondMedic follows ethical AI practices aligned with DPDP Act and ABDM standards.

Future of AI-Based Disease Detection in India

AI will continue to redefine diagnostics in India over the next decade.

Future developments include:

Deep AI for full-body scan interpretation
Genomic-based AI predictions
Emotion and mental health detection through AI
AI-assisted virtual triage systems
At-home AI diagnostic kits
National integrated AI health platforms

SecondMedic aims to lead in these innovations by integrating advanced predictive tools.

Conclusion

AI-based disease detection India is shaping a new era of proactive healthcare. By analyzing health patterns, detecting abnormalities early, and providing accurate risk assessment, AI empowers individuals to act before diseases progress. SecondMedic uses AI-driven diagnostic tools to support early detection, preventive care, and long-term health protection.

To explore AI-powered diagnostic support, visit www.secondmedic.com

References

NITI Aayog – AI for Healthcare in India
WHO – AI in Early Disease Detection
ICMR – Chronic Disease Patterns India
IMARC – Indian AI Healthcare Market
FICCI – AI and Precision Medicine India

Request A Callback

+91

By using this website/app, I confirm that I am at least 18 years old and consent to the processing of my personal data in accordance with the Terms of Service, Privacy Policy, and Declaration.